查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1662765

2030 年醫藥冷藏貨櫃市場預測：按產品類型、貨櫃尺寸、技術、運輸方式、應用、最終用戶和地區進行的全球分析

Reefer Container for Pharmaceutical Market Forecasts to 2030 - Global Analysis By Product Type, Container Size, Technology, Mode of Transport, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球醫藥冷藏貨櫃市場預計在 2024 年將達到 58.1 億美元，到 2030 年將達到 103.6 億美元，預測期內的複合年成長率為 10.1%。醫藥冷藏貨櫃是專門的冷藏運輸貨櫃，旨在運輸對溫度敏感的醫療產品（例如疫苗、生技藥品和某些藥物）期間保持受控的溫度環境。這些容器配備了先進的冷卻系統，以確保產品保持在特定的溫度範圍內，以保持功效和安全性。冷藏貨櫃在低溫運輸物流中發揮著至關重要的作用，確保醫藥產品從生產設施到世界各地分銷點的完整性。

生物製藥需求不斷成長

單株抗體、基因療法和疫苗等生物製藥需要嚴格的溫度控制才能維持穩定性和功效。隨著這些先進療法變得越來越普遍，特別是在腫瘤學和慢性病管理領域，對可靠的低溫運輸物流的需求也日益增加。冷藏貨櫃對於運輸這些易碎產品至關重要，可確保它們在運輸過程中保持在所需的溫度範圍內。對生物製藥日益成長的需求刺激了對溫控運輸解決方案的投資增加，並強調了有效低溫運輸管理的重要性。

溫度波動的風險

胰島素、生技藥品和疫苗等對溫度敏感的藥物，只要稍微超出所需的溫度範圍，其品質和有效性就會受到威脅。運輸過程中的溫度不穩定可能由設備故障、隔熱不足和外部環境等因素造成。這種風險凸顯了先進的監控系統、定期維護和即時追蹤以確保精確的溫度控制的重要性。可靠的低溫運輸操作至關重要，因為任何溫度完整性的喪失都可能導致昂貴的產品召回、品牌聲譽受損和法律後果。

提高對低溫運輸物流的認知

提高對低溫運輸物流的認知是促進醫藥冷凍箱產業發展的重要因素。隨著全球對疫苗、生技藥品和其他生物來源製品等溫度敏感藥物的需求不斷增加，在整個供應鏈中保持這些產品的完整性變得越來越重要。高效的低溫運輸管理有助於將溫度敏感物品保持在指定範圍內，從而避免產品劣化。冷藏貨櫃和溫控運輸選項的支出增加、更嚴格的監管以及消費者對更安全、更可靠藥品的需求不斷成長，都有助於提高供應鏈的效率和可靠性。

專用容器的可用性有限

製藥業面臨的一個障礙是專用冷凍貨櫃的供應有限，尤其是隨著溫控運輸需求的增加。儘管許多冷藏貨櫃是作為通用物品製造的，但標準冷藏貨櫃可能無法滿足醫藥產品高度專業化的溫度和濕度要求。由於缺乏此類專用容器，導致供應鏈瓶頸、延誤和額外成本，可能會阻礙醫藥物流的有效性。

COVID-19 的影響

新冠疫情大大促進了醫藥市場對冷藏貨櫃的需求。全球疫苗分發的迫切性，加上新冠疫苗和其他對溫度敏感的藥物對溫度的嚴格要求，導致對可靠的低溫運輸物流的需求激增。這導致了對先進冷藏技術的投資增加、供應鏈彈性提高以及全球對確保溫度敏感藥品運輸完整性的關注。

預計預測期內主動冷卻系統部分將成為最大的部分。

由於需要精確和持續的溫度控制來維持疫苗和生技藥品等溫度敏感產品的功效，主動冷卻系統部門預計將在預測期內佔據最大的市場佔有率。主動冷卻可確保運輸過程中的穩定條件，尤其是在遠距和波動的環境條件下。隨著製藥業對生物製藥和全球分銷的關注度日益提高，主動冷卻系統對於滿足嚴格的低溫運輸要求和監管標準至關重要。

預計預測期內物流供應商部門將以最高的複合年成長率成長。

由於對高效和溫控運輸解決方案的需求不斷成長，預計物流供應商部門將在預測期內呈現最高的成長率。隨著全球醫藥市場的成長，物流公司正在投資先進的低溫運輸技術，以滿足疫苗和生技藥品等溫度敏感產品的嚴格要求。供應商在確保產品完整性、法規遵循和及時交付方面發揮著至關重要的作用，推動了醫藥物流對專用冷凍集裝箱的需求。

比最大的地區

由於醫療保健、生物技術和製藥領域的快速成長，預計亞太地區將在預測期內佔據最大的市場佔有率。疫苗和生技藥品等溫度敏感產品的需求不斷增加，以及中國和印度等國家藥品生產的擴大，都推動了對可靠的低溫運輸物流的需求。基礎設施的不斷完善和監管的不斷推進進一步推動了全部區域溫控運輸解決方案的發展。

複合年成長率最高的地區

預計北美地區在預測期內將呈現最高的複合年成長率。這是因為該地區擁有強大的製藥製造基礎，並且對生技藥品、疫苗和其他溫度敏感藥物的需求不斷增加。 FDA 等嚴格的監管標準要求可靠的低溫運輸物流。此外，人們對生物製藥、技術進步和強大分銷網路的日益關注，進一步推動了對冷凍集裝箱的需求，以保持整個供應鏈中的產品完整性。

免費客製化服務

訂閱此報告的客戶可享有以下免費自訂選項之一：

  • 公司簡介
    • 對其他市場參與企業（最多 3 家公司）進行全面分析
    • 主要企業的 SWOT 分析（最多 3 家公司）
  • 地理細分
    • 根據客戶興趣對主要國家進行市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭性基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第 2 章 前言

  • 概述
  • 相關利益者
  • 研究範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二手研究資料資訊來源
    • 先決條件

第3章 市場走勢分析

  • 介紹
  • 驅動程式
  • 限制因素
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第 4 章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

第5章全球醫藥冷藏貨櫃市場（依產品類型）

  • 介紹
  • 標準冷藏貨櫃
  • 氣調冷藏貨櫃
  • 熱電容器
  • 其他

6. 全球醫藥冷藏貨櫃市場（依貨櫃尺寸）

  • 介紹
  • 20英尺
  • 40英尺
  • 高立方體

7. 全球醫藥冷藏貨櫃市場（按技術）

  • 介紹
  • 機械式冷凍系統
  • 主動冷卻系統
  • 被動冷卻系統

8. 全球醫藥冷藏貨櫃市場依運輸方式分類

  • 介紹
  • 搭船
  • 路
  • 鐵路

第9章全球醫藥冷藏貨櫃市場（按應用）

  • 介紹
  • 疫苗
  • 生物製藥
  • 胰島素和荷爾蒙
  • 臨床試驗數據
  • 電漿
  • 其他

第 10 章全球醫藥冷藏貨櫃市場（按最終用戶）

  • 介紹
  • 製藥商
  • 物流供應商
  • 分銷商/批發商
  • 其他

第 11 章全球醫藥冷藏貨櫃市場（按地區）

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第12章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第13章 公司概況

  • Maersk Line
  • CMA CGM Group
  • MSC Mediterranean Shipping Company
  • Hapag-Lloyd
  • Evergreen Marine Corporation
  • AP Moller-Maersk
  • ZIM Integrated Shipping Services
  • Kuehne+Nagel
  • China COSCO Shipping Corporation
  • DP World
  • Seaco Global
  • DHL Supply Chain
  • United Arab Shipping Company（UASC）
  • Cool Containers
  • Geodis Logistics
Product Code: SMRC28626

According to Stratistics MRC, the Global Reefer Container for Pharmaceutical Market is accounted for $5.81 billion in 2024 and is expected to reach $10.36 billion by 2030 growing at a CAGR of 10.1% during the forecast period. A reefer container for pharmaceuticals is a specialized refrigerated shipping container designed to maintain a controlled temperature environment during the transportation of temperature-sensitive pharmaceutical products, such as vaccines, biologics, and certain medicines. These containers are equipped with advanced cooling systems to ensure that products remain within specific temperature ranges, preserving their efficacy and safety. Reefer containers play a critical role in cold-chain logistics, ensuring the integrity of pharmaceutical products from production facilities to distribution points across the world.

Market Dynamics:

Driver:

Rising demand for biopharmaceuticals

Biopharmaceutical products, such as monoclonal antibodies, gene therapies, and vaccines, require stringent temperature control to maintain their stability and efficacy. As these advanced therapies become more prevalent, especially in oncology and chronic disease management, the need for reliable cold chain logistics intensifies. Reefer containers are essential for transporting these sensitive products, ensuring that they remain within the required temperature range throughout their journey. This growing demand for biopharmaceuticals is fueling increased investments in temperature-controlled shipping solutions and reinforcing the importance of effective cold chain management.

Restraint:

Risk of temperature fluctuations

The quality and effectiveness of pharmaceutical products that are sensitive to temperature, such insulin, biologics, and vaccinations, can be jeopardized by even minor departures from the necessary temperature range. Temperature instability during transportation may be caused by elements such as equipment failure, insufficient insulation, or outside environmental circumstances. In order to guarantee accurate temperature management, this risk emphasizes the significance of sophisticated monitoring systems, routine maintenance, and real-time tracking. Reliable cold chain operations are crucial since any compromise in temperature integrity could lead to expensive product recalls, harm to a brand's reputation, and legal repercussions.

Opportunity:

Growing awareness of cold chain logistics

Growing knowledge of cold chain logistics is a major factor propelling the pharmaceutical reefer container industry. Maintaining the integrity of medicines across the supply chain is of greater importance as the demand for temperature-sensitive medications, such as vaccines, biologics, and other biologically derived products, rises globally. Product degradation is avoided by maintaining temperature-sensitive items within specified ranges thanks to efficient cold chain management. The supply chain's overall efficiency and dependability have increased as a result of increased expenditures in reefer containers and temperature-controlled shipping options, as well as tighter regulations and consumer demand for safer, more dependable pharmaceutical products.

Threat:

Limited availability of specialized containers

The pharmaceutical industry has a hurdle due to the restricted supply of specialized reefer containers, particularly as the need for temperature-controlled shipping grows. Standard refrigerated containers may not always be able to meet the highly specialized temperature and humidity requirements of pharmaceutical items, even though many reefer containers are made for universal usage. The effectiveness of pharmaceutical logistics might be hampered by supply chain bottlenecks, delays, and additional expenses caused by the lack of such specialized containers.

Covid-19 Impact

The COVID-19 pandemic significantly boosted the demand for reefer containers in the pharmaceutical market. The urgent need for global vaccine distribution, coupled with the stringent temperature requirements for COVID-19 vaccines and other temperature-sensitive pharmaceuticals, drove a surge in demand for reliable cold chain logistics. This led to increased investment in advanced reefer technologies, improved supply chain resilience, and a heightened focus on ensuring the integrity of temperature-sensitive pharmaceutical shipments worldwide.

The active cooling systems segment is expected to be the largest during the forecast period

The active cooling systems segment is expected to account for the largest market share during the forecast period, driven by the need for precise, continuous temperature control to maintain the efficacy of temperature-sensitive products like vaccines and biologics. Active cooling ensures stable conditions during transportation, especially over long distances or in fluctuating environmental conditions. As the pharmaceutical industry increasingly focuses on biopharmaceuticals and global distribution, active cooling systems are vital to meet stringent cold chain requirements and regulatory standards.

The logistics providers segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the logistics providers segment is predicted to witness the highest growth rate, due to the rising demand for efficient, temperature-controlled transportation solutions. As the global pharmaceutical market grows, logistics companies are investing in advanced cold-chain technologies to meet the stringent requirements for temperature-sensitive products like vaccines and biologics. Providers play a critical role in ensuring product integrity, regulatory compliance, and timely delivery, driving the demand for specialized reefer containers in pharmaceutical logistics.

Region with largest share:

During the forecast period, Asia Pacific region is expected to hold the largest market share, due to rapid growth in healthcare, biotechnology, and pharmaceutical sectors. The increasing demand for temperature-sensitive products like vaccines and biologics, along with expanding pharmaceutical production in countries like China and India, has fueled the need for reliable cold-chain logistics. Enhanced infrastructure and regulatory developments further support the growth of temperature-controlled shipping solutions across the region.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to the region's strong pharmaceutical manufacturing base and growing demand for biologics, vaccines, and other temperature-sensitive drugs. Strict regulatory standards, such as those from the FDA, ensure the need for reliable cold chain logistics. Additionally, the increasing focus on biopharmaceuticals, advancements in technology, and robust distribution networks are further boosting the demand for reefer containers to maintain product integrity throughout the supply chain.

Key players in the market

Some of the key players profiled in the Reefer Container for Pharmaceutical Market include Maersk Line, CMA CGM Group, MSC Mediterranean Shipping Company, Hapag-Lloyd, Evergreen Marine Corporation, AP Moller-Maersk, ZIM Integrated Shipping Services, Kuehne + Nagel, China COSCO Shipping Corporation, DP World, Seaco Global, DHL Supply Chain, United Arab Shipping Company (UASC), Cool Containers, and Geodis Logistics.

Key Developments:

In September 2024, Maersk and Hapag-Lloyd announced their "Gemini Cooperation" to start in 2025 that would further improve the reliability of services and increase capacity by jointly operating a combined fleet of 290 vessels. It will underpin global trade routes, including those vital for pharmaceuticals.

In July 2024, MEDLOG, the logistics arm of MSC, has ceremoniously marked the start of construction of a 291,000 square foot state-of-the-art cold storage facility in Savannah, Georgia. The project is to symbolically signal a key addition to the export capability of poultry, pork and meat producers from the USA Southeast and Midwest.

Product Types Covered:

  • Standard Reefer Containers
  • Controlled-Atmosphere Reefer Containers
  • Thermoelectric Containers
  • Other Product Types

Container Sizes Covered:

  • 20 feet
  • 40 feet
  • High Cube

Technologies Covered:

  • Mechanical Refrigeration Systems
  • Active Cooling Systems
  • Passive Cooling Systems

Mode of Transports Covered:

  • Seaways
  • Roadways
  • Railways

Applications Covered:

  • Vaccines
  • Biopharmaceuticals
  • Insulin & Hormonal Drugs
  • Clinical Trial Material
  • Blood Plasma
  • Other Applications

End Users Covered:

  • Pharmaceutical Manufacturers
  • Logistics Providers
  • Distributors/Wholesalers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Reefer Container for Pharmaceutical Market, By Product Type

  • 5.1 Introduction
  • 5.2 Standard Reefer Containers
  • 5.3 Controlled-Atmosphere Reefer Containers
  • 5.4 Thermoelectric Containers
  • 5.5 Other Product Types

6 Global Reefer Container for Pharmaceutical Market, By Container Size

  • 6.1 Introduction
  • 6.2 20 feet
  • 6.3 40 feet
  • 6.4 High Cube

7 Global Reefer Container for Pharmaceutical Market, By Technology

  • 7.1 Introduction
  • 7.2 Mechanical Refrigeration Systems
  • 7.3 Active Cooling Systems
  • 7.4 Passive Cooling Systems

8 Global Reefer Container for Pharmaceutical Market, By Mode of Transport

  • 8.1 Introduction
  • 8.2 Seaways
  • 8.3 Roadways
  • 8.4 Railways

9 Global Reefer Container for Pharmaceutical Market, By Application

  • 9.1 Introduction
  • 9.2 Vaccines
  • 9.3 Biopharmaceuticals
  • 9.4 Insulin & Hormonal Drugs
  • 9.5 Clinical Trial Material
  • 9.6 Blood Plasma
  • 9.7 Other Applications

10 Global Reefer Container for Pharmaceutical Market, By End User

  • 10.1 Introduction
  • 10.2 Pharmaceutical Manufacturers
  • 10.3 Logistics Providers
  • 10.4 Distributors/Wholesalers
  • 10.5 Other End Users

11 Global Reefer Container for Pharmaceutical Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Maersk Line
  • 13.2 CMA CGM Group
  • 13.3 MSC Mediterranean Shipping Company
  • 13.4 Hapag-Lloyd
  • 13.5 Evergreen Marine Corporation
  • 13.6 AP Moller-Maersk
  • 13.7 ZIM Integrated Shipping Services
  • 13.8 Kuehne + Nagel
  • 13.9 China COSCO Shipping Corporation
  • 13.10 DP World
  • 13.11 Seaco Global
  • 13.12 DHL Supply Chain
  • 13.13 United Arab Shipping Company (UASC)
  • 13.14 Cool Containers
  • 13.15 Geodis Logistics

List of Tables

  • Table 1 Global Reefer Container for Pharmaceutical Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Reefer Container for Pharmaceutical Market Outlook, By Product Type (2022-2030) ($MN)
  • Table 3 Global Reefer Container for Pharmaceutical Market Outlook, By Standard Reefer Containers (2022-2030) ($MN)
  • Table 4 Global Reefer Container for Pharmaceutical Market Outlook, By Controlled-Atmosphere Reefer Containers (2022-2030) ($MN)
  • Table 5 Global Reefer Container for Pharmaceutical Market Outlook, By Thermoelectric Containers (2022-2030) ($MN)
  • Table 6 Global Reefer Container for Pharmaceutical Market Outlook, By Other Product Types (2022-2030) ($MN)
  • Table 7 Global Reefer Container for Pharmaceutical Market Outlook, By Container Size (2022-2030) ($MN)
  • Table 8 Global Reefer Container for Pharmaceutical Market Outlook, By 20 feet (2022-2030) ($MN)
  • Table 9 Global Reefer Container for Pharmaceutical Market Outlook, By 40 feet (2022-2030) ($MN)
  • Table 10 Global Reefer Container for Pharmaceutical Market Outlook, By High Cube (2022-2030) ($MN)
  • Table 11 Global Reefer Container for Pharmaceutical Market Outlook, By Technology (2022-2030) ($MN)
  • Table 12 Global Reefer Container for Pharmaceutical Market Outlook, By Mechanical Refrigeration Systems (2022-2030) ($MN)
  • Table 13 Global Reefer Container for Pharmaceutical Market Outlook, By Active Cooling Systems (2022-2030) ($MN)
  • Table 14 Global Reefer Container for Pharmaceutical Market Outlook, By Passive Cooling Systems (2022-2030) ($MN)
  • Table 15 Global Reefer Container for Pharmaceutical Market Outlook, By Mode of Transport (2022-2030) ($MN)
  • Table 16 Global Reefer Container for Pharmaceutical Market Outlook, By Seaways (2022-2030) ($MN)
  • Table 17 Global Reefer Container for Pharmaceutical Market Outlook, By Roadways (2022-2030) ($MN)
  • Table 18 Global Reefer Container for Pharmaceutical Market Outlook, By Railways (2022-2030) ($MN)
  • Table 19 Global Reefer Container for Pharmaceutical Market Outlook, By Application (2022-2030) ($MN)
  • Table 20 Global Reefer Container for Pharmaceutical Market Outlook, By Vaccines (2022-2030) ($MN)
  • Table 21 Global Reefer Container for Pharmaceutical Market Outlook, By Biopharmaceuticals (2022-2030) ($MN)
  • Table 22 Global Reefer Container for Pharmaceutical Market Outlook, By Insulin & Hormonal Drugs (2022-2030) ($MN)
  • Table 23 Global Reefer Container for Pharmaceutical Market Outlook, By Clinical Trial Material (2022-2030) ($MN)
  • Table 24 Global Reefer Container for Pharmaceutical Market Outlook, By Blood Plasma (2022-2030) ($MN)
  • Table 25 Global Reefer Container for Pharmaceutical Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 26 Global Reefer Container for Pharmaceutical Market Outlook, By End User (2022-2030) ($MN)
  • Table 27 Global Reefer Container for Pharmaceutical Market Outlook, By Pharmaceutical Manufacturers (2022-2030) ($MN)
  • Table 28 Global Reefer Container for Pharmaceutical Market Outlook, By Logistics Providers (2022-2030) ($MN)
  • Table 29 Global Reefer Container for Pharmaceutical Market Outlook, By Distributors/Wholesalers (2022-2030) ($MN)
  • Table 30 Global Reefer Container for Pharmaceutical Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.